InvestSMART

ResMed Inc. (ASX: RMD) - Announcements

Current share price for RMD : $32.580 0.03 (0.09%)+

ASX company news and announcements for ResMed Inc. (RMD) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All ResMed Inc. (RMD) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than ResMed Inc. (RMD), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for ResMed Inc. (RMD)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$18,575 Statement of changes in beneficial ownership 9 Oct 2026 1:16PM $32.590 $32.580 fallen by 0.03%
$18,575 Statement of CDIs on issue - RMD 5 Oct 2026 8:13AM $31.790 $32.580 risen by 2.49%
$18,575 Statement of changes in beneficial ownership 2 Oct 2026 8:21AM $31.550 $32.580 risen by 3.26%
$18,575 Statement of changes in beneficial ownership 2 Oct 2026 8:21AM $31.550 $32.580 risen by 3.26%
$18,575 Statement of changes in beneficial ownership 2 Oct 2026 8:21AM $31.550 $32.580 risen by 3.26%
$18,575 Statement of changes in beneficial ownership 2 Oct 2026 8:20AM $31.550 $32.580 risen by 3.26%
$18,575 Statement of changes in beneficial ownership 2 Oct 2026 8:20AM $31.550 $32.580 risen by 3.26%
$18,575 Notice of Annual General Meeting Additional Materials 2 Oct 2026 8:19AM $31.550 $32.580 risen by 3.26%
$18,575 Notice of Annual General Meeting/Proxy Form 2 Oct 2026 8:19AM $31.550 $32.580 risen by 3.26%
$18,575 Resmed to Report First Quarter Fiscal 2027 Results 2 Oct 2026 8:19AM $31.550 $32.580 risen by 3.26%
$18,575 Statement of changes in beneficial ownership 11 Sep 2026 8:17AM $30.300 $32.580 risen by 7.52%
$18,575 Statement of CDIs on issue - RMD 7 Sep 2026 10:35AM $31.495 $32.580 risen by 3.44%
$18,575 Statement of changes in beneficial ownership 7 Sep 2026 8:17AM $31.680 $32.580 risen by 2.84%
$18,575 Accelerated Share Repurchase Agreement Announcement 2 Sep 2026 8:22AM $33.190 $32.580 fallen by 1.84%
$18,575 LR 1.15.3 Compliance 28 Aug 2026 8:11AM $32.390 $32.580 risen by 0.59%
$18,575 Update - Dividend/Distribution - RMD 24 Aug 2026 8:01AM $31.940 $32.580 risen by 2%
$18,575 Details of Auditor Appointment/Resignation 18 Aug 2026 8:07AM $31.630 $32.580 risen by 3%
$18,575 Resmed Form 10-K Annual Report 14 Aug 2026 8:32AM $31.800 $32.580 risen by 2.45%
$18,575 Statement of changes in beneficial ownership 12 Aug 2026 8:15AM $31.230 $32.580 risen by 4.32%
$18,575 Deferral of Conversions between Australian and US Registers 7 Aug 2026 8:54AM $31.480 $32.580 risen by 3.49%
$18,575 Dividend/Distribution - RMD 7 Aug 2026 8:27AM $31.480 $32.580 risen by 3.49%
$18,575 Resmed Announces Results for the Fourth Quarter of FY2026 7 Aug 2026 8:26AM $31.480 $32.580 risen by 3.49%
$18,575 144 Report of proposed sale of securities 7 Aug 2026 8:25AM $31.480 $32.580 risen by 3.49%
$18,575 Statement of CDIs on issue - RMD 5 Aug 2026 2:37PM $31.525 $32.580 risen by 3.35%
$18,575 Statement of changes in beneficial ownership 10 Jul 2026 8:20AM $30.310 $32.580 risen by 7.49%

1 - 25 of 727 results

Page 1 of 30

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.